NICORA 5

Product Description

NICORA-5 is specifically designed for individuals who experience stable angina pectoris, which refers to heart-related chest discomfort stemming from inadequate blood flow to the heart muscle. This medication operates through a distinctive dual-action approach that effectively opens blood vessels, enhances oxygen delivery to the heart, and alleviates the cardiac workload. It is particularly beneficial for patients who do not respond well to standard first-line anti-anginal treatments or who are unable to tolerate them, ultimately leading to an improved quality of life and a decrease in angina occurrences. The dual mechanism includes the activation of potassium channels, which results in the relaxation and dilation of arterial blood vessels, reducing the resistance the heart encounters during pumping. Additionally, NICORA-5 acts as a nitrate-like vasodilator, releasing nitric oxide to further promote the widening of both arterial and venous vessels, facilitating a reduction in blood return to the heart. This comprehensive approach not only addresses present angina symptoms but also helps in preventing future episodes. By increasing the oxygen supply to the heart and decreasing the heart’s demand for oxygen, NICORA-5 supports better heart health and may offer cardioprotective effects. It serves as a crucial alternative for those who cannot tolerate traditional anti-anginal medications such as beta-blockers or calcium channel blockers.